UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Court rejects Kolon’s appeal over Invossa license revocation
A Seoul court turned down Kolon Life Science’s appeal for stopping the gove...
by Jeong Sae-im
|
2019-09-25 11:18
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo
|
2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo
|
2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo
|
2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo
|
2019-09-24 17:00
라인
Thyroidectomy ups depression risk by 1.81 folds within 2 months
Patients who undergo thyroidectomy face a steep increase in depression risk...
by Kim Eun-young
|
2019-09-24 17:00
라인
Why using end-to-end services should be part of a drug product strategy
Specialized services offered by end-to-end service providers are essential ...
by Lee Han-soo
|
2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
Helixmith said that it has failed to make conclusions due to data contamina...
by Lee Han-soo
|
2019-09-24 16:38
라인
KMA advises doctors to avoid ranitidine in heartburn treatment
After the U.S. regulator found potentially cancer-causing chemical N-Nitros...
by Choi Gwang-seok
|
2019-09-24 14:40
라인
How does GE Healthcare use AI for product development?
GE Healthcare drew keen attention by unveiling Edison, an intelligence plat...
by Park Gi-taek
|
2019-09-24 12:42
라인
Dog dewormer gets scarce amid rumors of efficacy in cancer
Korean cancer patients are rushing to pharmacies to buy fenbendazole, a dog...
by Lee Han-soo
|
2019-09-24 12:41
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
Hwail Pharmaceutical and SupexBNP said that they have registered a patent f...
by Lee Han-soo
|
2019-09-23 22:34
라인
Ministry advises smokers to stop using e-cigarettes
The Ministry of Health and Welfare has recommended smokers who use e-cigare...
by Lee Han-soo
|
2019-09-23 16:55
라인
FDA recommends Kolon to remanufacture Invossa’s second fluid
The U.S. Food and Drug Administration has recommended Kolon TissueGene to r...
by Jeong Sae-im
|
2019-09-23 15:32
라인
Dong-A ST's Aranesp biosimilar gets nod in Japan
Dong-A ST said that Sanwa Kagaku Kenkyusho (SKK), its Japanese partner, has...
by Lee Han-soo
|
2019-09-23 15:31
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im
|
2019-09-23 14:52
라인
Vuno, Daegu Fatima Hospital to cooperate on AI-based medical service
Vuno said that it would collaborate with Daegu Fatima Hospital to establish...
by Lee Han-soo
|
2019-09-23 14:52
라인
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
Roche Korea has received approval from the Ministry of Food and Drug Safety...
by Lee Han-soo
|
2019-09-23 13:28
라인
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’
“The DAPA-HF trial results announced in the recent European Society of Card...
by Kim Yun-mi
|
2019-09-23 11:45
라인
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’
Daewoong Pharmaceutical said its poster session on phase 1 clinical trial o...
by Lee Han-soo
|
2019-09-20 17:51
-
이전
91
92
93
94
95
96
97
98
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top